During year 3, clinical studies within the TransBioLine project are progressing in the enrolment of patients to move forward in the identification of novel biomarkers that reliably indicate specific organ injury during drug development.
Status of clinical studies per centre and organ work package as of 16 March 2022
[table id=9 /]
[table id=10 /]
[table id=11 /]
[table id=12 /]
[table id=13 /]
[table id=14 /]
enrolling: trial is running, patient recruitment is underway
approved: ethical approval has been received, patients not yet being recruited
submitted: study awaiting ethical approval, documents submitted to local ethical committee
not yet submitted: documents will be submitted for ethical approval shortly
completed: patients no longer being recruited
-: not planned/not applicable